Olaparib In Metastatic Breast Cancer

Clinical trial NCT03344965 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03344965
Sponsor: Beth Israel Deaconess Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer Invasive Breast Cancer Somatic Mutation Breast Cancer (BRCA1)Somatic Mutation Breast Cancer (BRCA2)CHEK2 Gene Mutation ATM Gene Mutation PALB2 Gene Mutation RAD51 Gene Mutation BRIP1 Gene Mutation NBN Gene Mutation

Start date: 2018-04-01
Primary completion: 2025-07-30
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.